Whole blood for prehospital transfusion did not reduce 30-day mortality compared to blood components
Trial shows no survival benefit for whole blood over components
This phase 3 cluster-randomized trial of 695 patients receiving whole blood and 298 receiving blood components found no statistically signif…
A large trial of trauma patients found that using whole blood instead of standard blood parts did not improve 30-day survival rates.
Systematic review examines early erythropoiesis-stimulating agents for preterm infants across multiple clinical outcomes and safety endpoints
Early blood boosters may lower severe brain injury risk in premature babies
A systematic review of 37 trials involving 6,724 preterm or low-birthweight infants found that early erythropoiesis-stimulating agents likel…
A review of 37 studies suggests early blood boosters might lower severe brain injury and severe gut illness in premature infants without rai…